EZH2 and cancer: Its dysregulation is linked to various cancers, with EZH2 interacting with oncogenes to promote tumorigenesis through both canonical and noncanonical pathways.460 Although EZH2 inhibitors are widely used, their effectiveness is limited by off-target effects and the development of resistance.461,462